Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E

Biochemical Journal

Volumn 453, Issue 1, 2013, Pages 37-47

  Mahrhold, Stefan ^a   Strotmeier, Jasmin ^a   Garcia Rodriguez, Consuelo ^b   Lou, Jianlong ^b   Marks, James D ^b   Rummel, Andreas ^a   Binz, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botulinum neurotoxin E; C terminal fragment of the heavy chain (H c fragment); Synaptic vesicle glycoprotein 2 (SV2); Synaptotagmin

Indexed keywords

BOTULINUM TOXIN B; BOTULINUM TOXIN E; CELL SURFACE RECEPTOR; GANGLIOSIDE; MONOCLONAL ANTIBODY; SV2 PROTEIN RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEMIDIAPHRAGM; NEUROTOXICITY; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; RAT; SYNAPTOSOME;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; BOTULINUM TOXINS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MUTATION; NERVE TISSUE PROTEINS; SYNAPTIC VESICLES;

EID: 84879011358     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130391     Document Type: Article

References (46)

1. 125I- labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J. Cell Biol. 103, 535-544
2. Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R. and Stevens, R. C. (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5, 898-902 (Pubitemid 28467413)
3. Swaminathan, S. and Eswaramoorthy, S. (2000) Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 7,693-699 (Pubitemid 30636683)
4. Kumaran, D., Eswaramoorthy, S., Furey, W., Navaza, J., Sax, M. and Swaminathan, S. (2009) Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J. Mol. Biol. 386, 233-245
5. Binz, T., Sikorra, S. and Mahrhold, S. (2010) Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering. Toxins 2,665-682
6. Montal, M. (2010) Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 79, 591-617
7. Binz, T. and Rummel, A. (2009) Cell entry strategy of clostridial neurotoxins. J. Neurochem. 109, 1584-1595
8. Muraro, L., Tosatto, S., Motterlini, L., Rossetto, O. and Montecucco, C. (2009) The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. Biochem. Biophys. Res. Commun. 380,76-80
9. Rummel, A. (2012) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr. Top. Microbiol. Immunol. 364, 61-90
10. Stenmark, P., Dupuy, J., Imamura, A., Kiso, M. and Stevens, R. C. (2008) Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b: insight into the toxin-neuron interaction. PLoS Pathog. 4, e1000129
11. Rummel, A., Mahrhold, S., Bigalke, H. and Binz, T. (2004) The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol. Microbiol. 51, 631-643 (Pubitemid 38233933)
12. Rummel, A., Hafner, K., Mahrhold, S., Darashchonak, N., Holt, M., Jahn, R., Beermann, S., Karnath, T., Bigalke, H. and Binz, T. (2009) Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J Neurochem. 110, 1942-1954
13. Benson, M. A., Fu, Z., Kim, J. J. and Baldwin, M. R. (2011) Unique ganglioside recognition strategies for clostridial neurotoxins. J. Biol. Chem. 286,34015-34022
14. Fu, Z., Chen, C., Barbieri, J. T., Kim, J. J. and Baldwin, M. R. (2009) Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 48, 5631-5641
15. Schmitt, J., Karalewitz, A., Benefield, D. A., Mushrush, D. J., Pruitt, R. N., Spiller, B. W., Barbieri, J. T. and Lacy, D. B. (2010) Structural analysis of botulinum neurotoxin type G receptor binding. Biochemistry 49, 5200-5205
16. Stenmark, P., Dong, M., Dupuy, J., Chapman, E. R. and Stevens, R. C. (2010) Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding. J. Mol. Biol. 397, 1287-1297
17. Rummel, A., Eichner, T., Weil, T., Karnath, T., Gutcaits, A., Mahrhold, S., Sandhoff, K., Proia, R. L., Acharya, K. R., Bigalke, H. and Binz, T. (2007) Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. U.S.A. 104, 359-364 (Pubitemid 46068036)
18. CC-domain of tetanus neurotoxin are required for toxicity. J. Mol.Biol. 326, 835-847
19. c fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J. Biol. Chem. 276, 32274-32281
20. Karalewitz, A. P., Fu, Z., Baldwin, M. R., Kim, J. J. and Barbieri, J. T. (2012) Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. J. Biol. Chem. 287, 40806-40816
21. Karalewitz, A. P., Kroken, A. R., Fu, Z., Baldwin, M. R., Kim, J. J. and Barbieri, J. T. (2010) Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA. Biochemistry 49, 8117-8126
22. Strotmeier, J., Gu, S., Jutzi, S., Mahrhold, S., Zhou, J., Pich, A., Eichner, T., Bigalke, H., Rummel, A., Jin, R. and Binz, T. (2011) The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Mol. Microbiol. 81,143-156
23. Kroken, A. R., Karalewitz, A. P., Fu, Z., Kim, J. J. and Barbieri, J. T. (2011) Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. J. Biol. Chem. 286, 26828-26837
24. Strotmeier, J., Lee, K., Volker, A. K., Mahrhold, S., Zong, Y., Zeiser, J., Zhou, J., Pich, A., Bigalke, H., Binz, T., Rummel, A. and Jin, R. (2010) Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Biochem. J. 431, 207-216
25. Montecucco, C. (1986) How do tetanus and botulinum toxins bind neuronal membranes? Trends Biochem. Sci. 11, 314-317
26. Dong, M., Richards, D. A., Goodnough, M. C., Tepp, W. H., Johnson, E. A. and Chapman, E. R. (2003) Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162, 1293-1303 (Pubitemid 37210885)
27. Rummel, A., Karnath, T., Henke, T., Bigalke, H. and Binz, T. (2004) Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279,30865-30870 (Pubitemid 38938022)
28. Dong, M., Tepp, W. H., Liu, H., Johnson, E. A. and Chapman, E. R. (2007) Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J. Cell Biol. 179,1511-1522
29. Nishiki, T., Kamata, Y., Nemoto, Y., Omori, A., Ito, T., Takahashi, M. and Kozaki, S. (1994) Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269, 10498-10503 (Pubitemid 24198248)
30. Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R. and Chapman, E. R. (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312, 592-596
31. Mahrhold, S., Rummel, A., Bigalke, H., Davletov, B. and Binz, T. (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 580, 2011-2014
32. Dong, M., Liu, H., Tepp, W. H., Johnson, E. A., Janz, R. and Chapman, E. R. (2008) Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol. Biol. Cell 19, 5226-5237
33. Peng, L., Tepp, W. H., Johnson, E. A. and Dong, M. (2011) Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog. 7, e1002008
34. Yeh, F. L., Dong, M., Yao, J., Tepp, W. H., Lin, G., Johnson, E. A. and Chapman, E. R. (2010) SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog. 6,e1001207
35. Peng, L., Berntsson, R. P., Tepp, W. H., Pitkin, R. M., Johnson, E. A., Stenmark, P. and Dong, M. (2012) Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. J. Cell Sci. 125, 3233-3242
36. Jin, R., Rummel, A., Binz, T. and Brunger, A. T. (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444, 1092-1095 (Pubitemid 46018531)
37. Chai, Q., Arndt, J. W., Dong, M., Tepp, W. H., Johnson, E. A., Chapman, E. R. and Stevens, R. C. (2006) Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 444, 1096-1100 (Pubitemid 46018532)
38. Fernandez-Recio, J., Totrov, M., Skorodumov, C. and Abagyan, R. (2005) Optimal docking area: a new method for predicting protein-protein interaction sites. Proteins 58,134-143 (Pubitemid 39665624)
39. Garcia-Rodriguez, C., Geren, I. N., Lou, J., Conrad, F., Forsyth, C., Wen, W., Chakraborti, S., Zao, H., Manzanarez, G., Smith, T. J. et al. (2011) Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng., Des. Sel. 24, 321-331
40. Nowakowski, A., Wang, C., Powers, D. B., Amersdorfer, P., Smith, T. J., Montgomery, V. A., Sheridan, R., Blake, R., Smith, L. A. and Marks, J. D. (2002) Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 99, 11346-11350 (Pubitemid 34920928)
41. Meng, Q., Garcia-Rodriguez, C., Manzanarez, G., Silberg, M. A., Conrad, F., Bettencourt, J., Pan, X., Breece, T., To, R., Li, M. et al. (2012) Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein. Anal. Biochem. 430, 141-150
42. Levy, R., Forsyth, C. M., LaPorte, S. L., Geren, I. N., Smith, L. A. and Marks, J. D. (2007) Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J. Mol. Biol. 365, 196-210 (Pubitemid 44830034)
43. Habermann, E., Dreyer, F. and Bigalke, H. (1980) Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch. Pharmacol. 311, 33-40 (Pubitemid 10146426)
44. Blake, 2nd, R. C., Pavlov, A. R. and Blake, D. A. (1999) Automated kinetic exclusion assays to quantify protein binding interactions in homogenous solution. Anal. Biochem. 272, 123-134 (Pubitemid 29364974)
45. Garcia-Rodriguez, C., Levy, R., Arndt, J. W., Forsyth, C. M., Razai, A., Lou, J., Geren, I., Stevens, R. C. and Marks, J. D. (2007) Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin. Nat. Biotechnol. 25, 107-116 (Pubitemid 46087909)
46. Pirazzini, M., Rossetto, O., Bolognese, P., Shone, C. C. and Montecucco, C. (2011) Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons. Cell. Microbiol. 13, 1731-1743